Correlations among steroid fear, acceptability, usage frequency, quality of life and disease severity in childhood eczema

References

• Foley P, Zuo Y, Plunkett A, Marks R. The frequency of common skin conditions in preschool-age children in Australia: atopic dermatitis. Arch Dermatol. 2001;137:293–300
   PubMed Web of Science ®Google Scholar
• Leung R, Wong G, Lau J, et al. Prevalence of asthma and allergy in Hong Kong schoolchildren: an ISAAC study. Eur Respir J. 1997;10:354–60
   PubMed Web of Science ®Google Scholar
• Emerson RM, Williams HC, Allen BR. Severity distribution of atopic dermatitis in the community and its relationship to secondary referral. Br J Dermatol. 1998;139:73–6
   PubMed Web of Science ®Google Scholar
• Leung AK, Hon KL, Robson WL. Atopic dermatitis. Adv Pediatr. 2007;54:241–73
   PubMedGoogle Scholar
• Hon KL, Pong NH, Wang SS, et al. Acceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients. Drugs R D. 2013;13:37–42
   PubMedGoogle Scholar
• Hon KL, Wang SS, Pong NH, Leung TF. The ideal moisturizer: a survey of parental expectations and practice in childhood-onset eczema. J Dermatolog Treat. 2012;24:7–12
   PubMed Web of Science ®Google Scholar
• Hon KL, Ching GK, Leung TF, et al. Estimating emollient usage in patients with eczema. Clin Exp Dermatol. 2010;35:22–6
   PubMed Web of Science ®Google Scholar
• Hon KL, Leung TF, Kam WY, et al. Dietary restriction and supplementation in children with atopic eczema. Clin Exp Dermatol. 2006;31:187–91
   PubMed Web of Science ®Google Scholar
• Hon KL, Wang SS, Lau Z, et al. Pseudoceramide for childhood eczema: does it work? Hong Kong Med J. 2011;17:132–6
   PubMedGoogle Scholar
• Hon KL, Leung AK. Use of ceramides and related products for childhood-onset eczema. Recent Pat Inflamm Allergy Drug Discov. 2012;1:12–19
   Google Scholar
• Hon KL, Leung TF, Lam MC, et al. Eczema exacerbation and food atopy beyond infancy: how should we advise Chinese parents about dietary history, eczema severity, and skin prick testing? Adv Ther. 2007;24:223–30
   PubMed Web of Science ®Google Scholar
• Hon KL, Leung TF, Yau HC, Chan T. Paradoxical use of oral and topical steroids in steroid-phobic patients resorting to traditional Chinese medicines. World J Pediatr. 2012;8:263–7
   PubMed Web of Science ®Google Scholar
• Patterson R, Walker CL, Greenberger PA, Sheridan EP. Prednisonephobia. Allergy Proc. 1989;10:423–8
   PubMedGoogle Scholar
• Charman C, Williams H. Outcome measures of disease severity in atopic eczema. Arch Dermatol. 2000;136:763–9
   PubMed Web of Science ®Google Scholar
• Hon KL, Kam WY, Leung TF, et al. Steroid fears in children with eczema. Acta Paediatrica. 2006;95:1451–5
   PubMed Web of Science ®Google Scholar
• Aubert-Wastiaux H, Moret L, Le Rhun A, et al. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency. Br J Dermatol. 2011;165:808–14
   PubMed Web of Science ®Google Scholar
• Kojima R, Fujiwara T, Matsuda A, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30:29–35
   PubMed Web of Science ®Google Scholar
• Moret L, Anthoine E, Aubert-Wastiaux H, et al. TOPICOP(c): a new scale evaluating topical corticosteroid phobia among atopic dermatitis outpatients and their parents. PLoS One. 2013;8:e76493
   PubMed Web of Science ®Google Scholar
• Williams HC, Burney PG, Pembroke AC, Hay RJ. The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation. Br J Dermatol. 1994;131:406–16
   PubMed Web of Science ®Google Scholar
• Emerson RM, Charman CR, Williams HC. The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol. 2000;142:288–97
   PubMed Web of Science ®Google Scholar
• Hon KL, Ma KC, Wong E, et al. Validation of a self-administered questionnaire in Chinese in the assessment of eczema severity. Pediatr Dermatol. 2003;20:465–9
   PubMed Web of Science ®Google Scholar
• Chuh AA. Validation of a Cantonese version of the Children’s Dermatology Life Quality Index. Pediatr Dermatol. 2003;20:479–81
   PubMed Web of Science ®Google Scholar
• Hon KL, Kam WY, Lam MC, et al. CDLQI, SCORAD and NESS: are they correlated? Qual Life Res. 2006;15:1551–8
   PubMed Web of Science ®Google Scholar
• Waters A, Sandhu D, Beattie P, et al. Severity stratification of Children’s Dermatology Life Quality Index (CDLQI) scores. Br J Dermatol. 2010;163:121
   PubMed Web of Science ®Google Scholar
• Hon KL, Wong KY, Leung TF, et al. Comparison of skin hydration evaluation sites and correlations among skin hydration, transepidermal water loss, SCORAD Index, Nottingham Eczema Severity Score, and quality of life in patients with atopic dermatitis. Am J Clin Dermatol. 2008;9:45–50
   PubMed Web of Science ®Google Scholar
• Tang TS, Bieber T, Williams HC. Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful? J Allergy Clin Immunol. 2014;133:1615–25
   PubMed Web of Science ®Google Scholar
• Torley D, Futamura M, Williams HC, Thomas KS. What’s new in atopic eczema? An analysis of systematic reviews published in 2010-11. Clin Exp Dermatol. 2013;38:449–56
   PubMed Web of Science ®Google Scholar
• Schmitt J, von KL, Svensson A, Apfelbacher C. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol. 2011;164:415–28
   PubMed Web of Science ®Google Scholar
• Wollenberg A, Frank R, Kroth J, Ruzicka T. Proactive therapy of atopic eczema–an evidence-based concept with a behavioral background. J Dtsch Dermatol Ges. 2009;7:117–21
   PubMed Web of Science ®Google Scholar
• Ellison JA, Patel LM, Ray DW, et al. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics. 2000;105:794–9
   PubMed Web of Science ®Google Scholar
• Thomas KS, Armstrong S, Avery A, et al. Randomised controlled trial of short bursts of a potent topical corticosteroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. BMJ. 2002;324:768
   PubMed Web of Science ®Google Scholar
• Friedlander SF, Hebert AA, Allen DB. Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months. J Am Acad Dermatol. 2002;46:387–93
   PubMed Web of Science ®Google Scholar